(Q43487343)

23 November 2017

title

Granulocyte, monocyte/macrophage apheresis for inflammatory bowel disease: the first 100 patients treated in Scandinavia (English)

1 reference

inflammatory bowel diseases

23 November 2017

0 references

1 reference

1 reference

3

Morten Vatn

1 reference

23 November 2017

Tryggve Ljung

1

1 reference

23 November 2017

Ole Østergaard Thomsen

2

1 reference

23 November 2017

Per Karlén

4

1 reference

23 November 2017

Lars Norman Karlsen

5

1 reference

23 November 2017

Curt Tysk

6

1 reference

23 November 2017

Stefan U Nilsson

7

1 reference

23 November 2017

Anders Kilander

8

1 reference

23 November 2017

Rolf Gillberg

9

1 reference

23 November 2017

Olof Grip

10

1 reference

23 November 2017

Stefan Lindgren

11

1 reference

23 November 2017

Ragnar Befrits

12

1 reference

23 November 2017

Robert Löfberg

13

1 reference

23 November 2017

language of work or name

1 reference

1 February 2007

1 reference

Scandinavian Journal of Gastroenterology

23 November 2017

published in

1 reference

23 November 2017

volume

42

1 reference

23 November 2017

issue

2

1 reference

23 November 2017

page(s)

221-227

1 reference

Standard therapy of Crohn's disease.

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00365520600979369

Medical therapy for ulcerative colitis 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600979369

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600979369

Infliximab for the treatment of fistulas in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600979369

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600979369

The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600979369

Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600979369

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600979369

Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600979369

Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600979369

Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600979369

Infliximab for induction and maintenance therapy for ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600979369

Recent developments in the immunology of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600979369

Inflammatory bowel disease: etiology and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600979369

Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600979369

Selective granulocyte and monocyte adsorptive apheresis as a first-line treatment for steroid naïve patients with active ulcerative colitis: a prospective uncontrolled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600979369

Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600979369

Clinical evaluation of granulocyte/monocyte apheresis therapy for active ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600979369

Cortisone and corticotrophin in ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600979369

Venous thromboembolism in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600979369

Granulocytapheresis is useful as an alternative therapy in patients with steroid-refractory or -dependent ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520600979369

10.1080/00365520600979369

21 January 2018

Identifiers

DOI

1 reference

23 November 2017

1 reference